Richard Sullivan: Words like revolutionary and game-changing have been liberally applied to the multi-cancer early detection test GRAIL-Galleri
Richard Sullivan posted on LinkedIn:
“Words like revolutionary and game-changing have been liberally applied to the multi-cancer early detection test GRAIL-Galleri. It’s been hailed as the answer to all the UK’s early detection and late diagnosis problems.
A panacea for primary care and even a possible new population screening tool. There has been, as well, extraordinary political capture to prematurely push the research program into clinical practice.
In this Lancet op-ed led by Prof Clare Turnbull from the Royal Marsden we ask, GRAIL-Galleri: why the special treatment?”
Read further.
Source: Richard Sullivan/LinkedIn
Richard Sullivan is a Professor of Cancer and Global Health at King’s College London, and Director of the King’s Institute of Cancer Policy and co-Director of the Conflict and Health Research Group. His research interests extend from global cancer to conflict & health. He has worked on a number of Lancet and Lancet Oncology commissions, currently the Lancet Commission on Global Diagnostics and the Lancet Oncology European Cancer Research Commission.
Dr. Sullivan’s work contributes to capacity building in conflict and health, and humanitarian medicine, particularly in the Middle East and North Africa, as well as programs in women’s health and cancer, digital innovation and a wide range of global health security project. He is an NCD advisor to the WHO, a member of the National Cancer Grid of India and advisor (civil-military) to Save the Children.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023